How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized?
Related Posts
Ahn HY, Walters JB, Avila R, Oh S, Seo SG, Kim JU, Park J, Yoo S, Choi YS, Kim TY, Liu J, Yoo JY, Weissleder[...]
Trinh K, Dries A, Boulier K, Wang J. Incidence of positive genetic testing among patients referred for cardiac positron emission tomography. J Med Genet. 2025[...]
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, Kang E, Ma F, Chiang J, Li YR, Zhu Y, Huang J, Fung[...]